Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells

Molecular Metabolism

Volumn 2, Issue 4, 2013, Pages 376-392

  Engelstoft, Maja S ^a,b   Park, Won mee ^c   Sakata, Ichiro ^c   Kristensen, Line V ^a,b   Husted, Anna Sofie ^a,b   Osborne Lawrence, Sherri ^c   Piper, Paul K ^c   Walker, Angela K ^c   Pedersen, Maria H ^a,b   Nøhr, Mark K ^a,b   Pan, Jie ^d   Sinz, Christopher J ^d   Carrington, Paul E ^d   Akiyama, Taro E ^d   Jones, Robert M ^e   Tang, Cong ^f   Ahmed, Kashan ^f   Offermanns, Stefan ^f   Egerod, Kristoffer L ^a,b   Zigman, Jeffrey M ^c   Schwartz, Thue W ^a,b   more..

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e ARENA PHARMACEUTICALS   (United States)

^f MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Enteroendocrine; G protein signaling; Ghrelin; GPCR; Metabolites; Secretion

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCIUM SENSING RECEPTOR; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 43; G PROTEIN COUPLED RECEPTOR 81; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HORMONE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER; PROTEIN G ALPHA SUBUNIT OA; PROTEIN G ALPHA SUBUNIT OB; PROTEIN G ALPHA SUBUNIT Z; SEVEN TRANSMEMBRANE G PROTEIN COUPLED RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GASTRIC GHRELIN CELL; GASTRIC MUCOSAL CELL CULTURE; GENOTYPE; HORMONAL REGULATION; HORMONE INHIBITION; HORMONE RELEASE; IC 50; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH MUCOSA;

EID: 84889093491     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.08.006     Document Type: Article

References (123)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402(6762):656-660.
2. Kumar J., Chuang J.C., Na E.S., Kuperman A., Gillman A.G., Mukherjee S., et al. Differential effects of chronic social stress and fluoxetine on meal patterns in mice. Appetite 2013, 64:81-88.
3. Verhulst P.J., Depoortere I. Ghrelin's second life: from appetite stimulator to glucose regulator. World Journal of Gastroenterology 2012, 18(25):3183-3195.
4. Kirchner H., Heppner K.M., Tschop M.H. The role of ghrelin in the control of energy balance. Handbook of Experimental Pharmacology 2012, 209:161-184.
5. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806):908-913.
6. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50(8):1714-1719.
7. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141(11):4255-4261.
8. Williams D.L., Cummings D.E., Grill H.J., Kaplan J.M. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 2003, 144(7):2765-2767.
9. Overduin J., Frayo R.S., Grill H.J., Kaplan J.M., Cummings D.E. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 2005, 146(2):845-850.
10. Foster-Schubert K.E., Overduin J., Prudom C.E., Liu J., Callahan H.S., Gaylinn B.D., et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. Journal of Clinical Endocrinology and Metabolism 2008, 93(5):1971-1979.
11. Sakata I., Park W.M., Walker A.K., Piper P.K., Chuang J.C., Osborne-Lawrence S., et al. Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells. American Journal of Physiology - Endocrinology and Metabolism 2012, 302(10):E1300-E1310.
12. Gagnon J., Anini Y. Insulin and norepinephrine regulate ghrelin secretion from a rat primary stomach cell culture. Endocrinology 2012, 153(8):3646-3656.
13. Lippl F., Kircher F., Erdmann J., Allescher H.D., Schusdziarra V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regulatory Peptides 2004, 119(1-2):93-98.
14. Anderwald C., Brabant G., Bernroider E., Horn R., Brehm A., Waldhausl W., et al. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 2003, 52(7):1792-1798.
15. Flanagan D.E., Evans M.L., Monsod T.P., Rife F., Heptulla R.A., Tamborlane W.V., et al. The influence of insulin on circulating ghrelin. American Journal of Physiology - Endocrinology and Metabolism 2003, 284(2):E313-E316.
16. Leonetti F., Iacobellis G., Ribaudo M.C., Zappaterreno A., Tiberti C., Iannucci C.V., et al. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity. Regulatory Peptides 2004, 122(3):179-183.
17. Saad M.F., Bernaba B., Hwu C.M., Jinagouda S., Fahmi S., Kogosov E., et al. Insulin regulates plasma ghrelin concentration. Journal of Clinical Endocrinology and Metabolism 2002, 87(8):3997-4000.
18. McCowen K.C., Maykel J.A., Bistrian B.R., Ling P.R. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. Journal of Endocrinology 2002, 175(2). (R7-11).
19. Caixas A., Bashore C., Nash W., Pi-Sunyer F., Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. Journal of Clinical Endocrinology and Metabolism 2002, 87(4):1902.
20. Schaller G., Schmidt A., Pleiner J., Woloszczuk W., Wolzt M., Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003, 52(1):16-20.
21. Degen L., Drewe J., Piccoli F., Grani K., Oesch S., Bunea R., et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2007, 292(4):R1391-R1399.
22. Brennan I.M., Otto B., Feltrin K.L., Meyer J.H., Horowitz M., Feinle-Bisset C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides 2007, 28(3):607-611.
23. Rudovich N.N., Nikiforova V.J., Otto B., Pivovarova O., Gogebakan O., Erban A., et al. Metabolomic linkage reveals functional interaction between glucose-dependent insulinotropic polypeptide and ghrelin in humans. American Journal of Physiology - Endocrinology and Metabolism 2011, 301(4):E608-E617.
24. Hagemann D., Holst J.J., Gethmann A., Banasch M., Schmidt W.E., Meier J.J. Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. Regulatory Peptides 2007, 143(1-3):64-68.
25. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. New England Journal of Medicine 2003, 349(10):941-948.
26. Iwakura H., Ariyasu H., Hosoda H., Yamada G., Hosoda K., Nakao K., et al. Oxytocin and dopamine stimulate ghrelin secretion by the ghrelin-producing cell line, MGN3-1 in vitro. Endocrinology 2011, 152(7):2619-2625.
27. Shimada M., Date Y., Mondal M.S., Toshinai K., Shimbara T., Fukunaga K., et al. Somatostatin suppresses ghrelin secretion from the rat stomach. Biochemical and Biophysical Research Communications 2003, 302(3):520-525.
28. de la Cour C.D., Norlen P., Hakanson R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regulatory Peptides 2007, 143(1-3):118-126.
29. Murakami N., Hayashida T., Kuroiwa T., Nakahara K., Ida T., Mondal M.S., et al. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. Journal of Endocrinology 2002, 174(2):283-288.
30. Ito T., Thidarmyint H., Murata T., Inoue H., Neyra R.M., Kuwayama H. Effects of peripheral administration of PYY3-36 on feed intake and plasma acyl-ghrelin levels in pigs. Journal of Endocrinology 2006, 191(1):113-119.
31. Gomez G., Englander E.W., Greeley G.H. Nutrient inhibition of ghrelin secretion in the fasted rat. Regulatory Peptides 2004, 117(1):33-36.
32. Qader S.S., Salehi A., Hakanson R., Lundquist I., Ekelund M. Long-term infusion of nutrients (total parenteral nutrition) suppresses circulating ghrelin in food-deprived rats. Regulatory Peptides 2005, 131(1-3):82-88.
33. Zhao T.J., Sakata I., Li R.L., Liang G., Richardson J.A., Brown M.S., et al. Ghrelin secretion stimulated by {beta}1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(36):15868-15873.
34. Mundinger T.O., Cummings D.E., Taborsky G.J. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 2006, 147(6):2893-2901.
35. Broglio F., Gottero C., Van Koetsveld P., Prodam F., Destefanis S., Benso A., et al. Acetylcholine regulates ghrelin secretion in humans. Journal of Clinical Endocrinology and Metabolism 2004, 89(5):2429-2433.
36. Ao Y., Go V.L., Toy N., Li T., Wang Y., Song M.K., et al. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion. Endocrinology 2006, 147(12):6004-6010.
37. Hosoda H., Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regulatory Peptides 2008, 146(1-3):12-18.
38. Williams D.L., Grill H.J., Cummings D.E., Kaplan J.M. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 2003, 144(12):5184-5187.
39. Engelstoft M.S., Egerod K.L., Holst B., Schwartz T.W. A gut feeling for obesity: 7TM sensors on enteroendocrine cells. Cell Metabolism 2008, 8(6):447-449.
40. Tolhurst G., Reimann F., Gribble F.M. Intestinal sensing of nutrients. Handbook of Experimental Pharmacology. (209) 2012, 309-335.
41. Sakata I., Nakano Y., Osborne-Lawrence S., Rovinsky S.A., Lee C.E., Perello M., et al. Characterization of a novel ghrelin cell reporter mouse. Regulatory Peptides 2009, 155(1-3):91-98.
42. Nohr M.K., Pedersen M.H., Gille A., Egerod K.L., Engelstoft M.S., Husted A.S., et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 2013, 154(10):3552-3564.
43. Regard J.B., Kataoka H., Cano D.A., Camerer E., Yin L., Zheng Y.W., et al. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. Journal of Clinical Investigation 2007, 117(12):4034-4043.
44. Shi, D.F., Song, J., Ma, J., Novack, A., Pham, P., Nashashibi, I., Rabbat, C.J., and Chen, X., 2010. GPR120 receptor agonists and uses thereof. Metabolex, Inc. WO 2010/080537.
45. Boatman, P.D., Bruce, M.A., Chu, Z.L., and Leonard, J.N., 2006. GPR41 and modulators thereof for the treatment of insulin-related disorders. PCT International Application. p. WO 2006052566.
46. Hald A., Rono B., Lund L.R., Egerod K.L. LPS counter regulates RNA expression of extracellular proteases and their inhibitors in murine macrophages. Mediators of Inflammation 2012, 2012:157894.
47. Egerod K.L., Engelstoft M.S., Grunddal K.V., Nohr M.K., Secher A., Sakata I., et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 2012, 153(12):5782-5795.
48. Kostenis E. Potentiation of GPCR-signaling via membrane targeting of G-protein α subunits. Journal of Receptors and Signal Transduction 2002, 22:267-281.
49. Gliddon B.L., Nguyen N.V., Gunn P.A., Gleeson P.A., van Driel I.R. Isolation, culture and adenoviral transduction of parietal cells from mouse gastric mucosa. Biomedical Materials 2008, 3(3):034117.
50. Yanovsky Y., Zigman J.M., Kernder A., Bein A., Sakata I., Osborne-Lawrence S., et al. Proton- and ammonium-sensing by histaminergic neurons controlling wakefulness. Frontiers in Systems Neuroscience 2012, 6:23.
51. Kumar A., Goel A., Paul S. Re: Urodynamic Testing - is it a useful tool in the management of children with cutaneous stigmata of occult spinal dysraphism?: L. T. Lavallee, M. P. Leonard, C. Dubois and L. A. Guerra. Journal of Urology 2013, 189:678-683. ([190(2): p. 812-3]).
52. Garg M., Singh V., Kumar A., Re Osman, et al. Clinically insignificant residual fragments: an acceptable term in the computed tomography era?. Urology 2013, 82(2):496-497.
53. Reimann F., Habib A.M., Tolhurst G., Parker H.E., Rogers G.J., Gribble F.M. Glucose sensing in L cells: a primary cell study. Cell Metabolism 2008, 8(6):532-539.
54. Briscoe C.P., Peat A.J., McKeown S.C., Corbett D.F., Goetz A.S., Littleton T.R., et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. British Journal of Pharmacology 2006, 148(5):619-628.
55. Lee T., Schwandner R., Swaminath G., Weiszmann J., Cardozo M., Greenberg J., et al. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Molecular Pharmacology 2008, 74(6):1599-1609.
56. Tolhurst G., Heffron H., Lam Y.S., Parker H.E., Habib A.M., Diakogiannaki E., et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012, 61(2):364-371.
57. Goodwin M.L., Harris J.E., Hernandez A., Gladden L.B. Blood lactate measurements and analysis during exercise: a guide for clinicians. Journal of Diabetes Science and Technology 2007, 1(4):558-569.
58. Dvorak C.A., Liu C., Shelton J., Kuei C., Sutton S.W., Lovenberg T.W., et al. Identification of hydroxybenzoic acids as selective lactate receptor (GPR81) agonists with antilipolytic effects. ACS Medicinal Chemistry Letters 2012, 3(8):637-639.
59. Conigrave A.D., Quinn S.J., Brown E.M. l-amino acid sensing by the extracellular Ca2+-sensing receptor. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(9):4814-4819.
60. Nemeth E.F., Steffey M.E., Fox J. The parathyroid calcium receptor: a novel therapeutic target for treating hyperparathyroidism. Pediatric Nephrology 1996, 10(3):275-279.
61. Feng J., Petersen C.D., Coy D.H., Jiang J.K., Thomas C.J., Pollak M.R., et al. Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(41):17791-17796.
62. Liou A.P., Sei Y., Zhao X., Feng J., Lu X., Thomas C., et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to l-phenylalanine in acutely isolated intestinal I cells. American Journal of Physiology - Gastrointestinal and Liver Physiology 2011, 300(4):G538-G546.
63. Mace O.J., Schindler M., Patel S. The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. Journal of Physiology 2012, 590(Pt 12):2917-2936.
64. Grieco P., Han G., Weinberg D., Van der Ploeg L.H., Hruby V.J. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochemical and Biophysical Research Communications 2002, 292(4):1075-1080.
65. Moller C.L., Raun K., Jacobsen M.L., Pedersen T.A., Holst B., Conde-Frieboes K.W., et al. Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved. Molecular and Cellular Endocrinology 2011, 341(1-2):9-17.
66. Lu X., Zhao X., Feng J., Liou A.P., Anthony S., Pechhold S., et al. Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice. American Journal of Physiology - Gastrointestinal and Liver Physiology 2012, 303(3):G367-G376.
67. Tulipano G., Soldi D., Bagnasco M., Culler M.D., Taylor J.E., Cocchi D., et al. Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 2002, 143(4):1218-1224.
68. Ignatov A., Lintzel J., Kreienkamp H.J., Schaller H.C. Sphingosine-1-phosphate is a high-affinity ligand for the G protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+ release by activating the sphingosine-kinase pathway. Biochemical and Biophysical Research Communications 2003, 311(2):329-336.
69. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. Journal of Biological Chemistry 2004, 279(26):27008-27016.
70. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nature Chemical Biology 2006, 2(4):207-212.
71. Zbucki R.L., Sawicki B., Hryniewicz A., Winnicka M.M. Cannabinoids enhance gastric X/A-like cells activity. Folia Histochemica et Cytobiologica 2008, 46(2):219-224.
72. Madison L.D., Scarlett J.M., Levasseur P., Zhu X., Newcomb K., Batra A., et al. Prostacyclin signaling regulates circulating ghrelin during acute inflammation. Journal of Endocrinology 2008, 196(2):263-273.
73. Wettschureck N., Offermanns S. Mammalian G proteins and their cell type specific functions. Physiological Reviews 2005, 85(4):1159-1204.
74. Janssen S., Laermans J., Verhulst P.J., Thijs T., Tack J., Depoortere I. Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(5):2094-2099.
75. Huang M.H., Nguyen V., Wu Y., Rastogi S., Lui C.Y., Birnbaum Y., et al. Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovascular Research 2009, 84(3):452-460.
76. Nguyen V.T., Wu Y., Guillory A.N., McConnell B.K., Fujise K., Huang M.H. Delta-opioid augments cardiac contraction through beta-adrenergic and CGRP-receptor co-signaling. Peptides 2012, 33(1):77-82.
77. Green T., Dockray G.J. Calcitonin gene-related peptide and substance P in afferents to the upper gastrointestinal tract in the rat. Neuroscience Letters 1987, 76(2):151-156.
78. Holzer P. Role of visceral afferent neurons in mucosal inflammation and defense. Current Opinion in Pharmacology 2007, 7(6):563-569.
79. Konturek P.C., Brzozowski T., Walter B., Burnat G., Hess T., Hahn E.G., et al. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. European Journal of Pharmacology 2006, 536(1-2):171-181.
80. Sibilia V., Rindi G., Pagani F., Rapetti D., Locatelli V., Torsello A., et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003, 144(1):353-359.
81. Zaki M., Coudron P.E., McCuen R.W., Harrington L., Chu S., Schubert M.L. H. pylori acutely inhibits gastric secretion by activating CGRP sensory neurons coupled to stimulation of somatostatin and inhibition of histamine secretion. American Journal of Physiology - Gastrointestinal and Liver Physiology 2013, 304(8):G715-G722.
82. Erdmann J., Lippl F., Schusdziarra V. Differential effect of protein and fat on plasma ghrelin levels in man. Regulatory Peptides 2003, 116(1-3):101-107.
83. Tannous dit El Khoury D., Obeid O., Azar S.T., Hwalla N. Variations in postprandial ghrelin status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Annals of Nutrition and Metabolism 2006, 50(3):260-269.
84. Gormsen L.C., Gjedsted J., Gjedde S., Vestergaard E.T., Christiansen J.S., Jorgensen J.O., et al. Free fatty acids decrease circulating ghrelin concentrations in humans. European Journal of Endocrinology 2006, 154(5):667-673.
85. Gormsen L.C., Nielsen C., Gjedsted J., Gjedde S., Vestergaard E.T., Christiansen J.S., et al. Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. Clinical Endocrinology (Oxford) 2007, 66(5):641-645.
86. Karpe F., Dickmann J.R., Frayn K.N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011, 60(10):2441-2449.
87. Sommer F., Backhed F. The gut microbiota - masters of host development and physiology. Nature Reviews Microbiology 2013, 11(4):227-238.
88. Muir J.G., Lu Z.X., Young G.P., Cameron-Smith D., Collier G.R., O'Dea K. Resistant starch in the diet increases breath hydrogen and serum acetate in human subjects. American Journal of Clinical Nutrition 1995, 61(4):792-799.
89. Peters S.G., Pomare E.W., Fisher C.A. Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 1992, 33(9):1249-1252.
90. Tarini J., Wolever T.M. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Applied Physiology, Nutrition, and Metabolism 2010, 35(1):9-16.
91. Vitaglione P., Lumaga R.B., Stanzione A., Scalfi L., Fogliano V. beta-Glucan-enriched bread reduces energy intake and modifies plasma ghrelin and peptide YY concentrations in the short term. Appetite 2009, 53(3):338-344.
92. Gruendel S., Garcia A.L., Otto B., Mueller C., Steiniger J., Weickert M.O., et al. Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans. Journal of Nutrition 2006, 136(6):1533-1538.
93. Lundquist F., Tygstrup N., Winkler K., Mellemgaard K., Munck-Petersen S. Ethanol metabolism and production of free acetate in the human liver. Journal of Clinical Investigation 1962, 41:955-961.
94. Szulc M., Mikolajczak P.L., Geppert B., Wachowiak R., Dyr W., Bobkiewicz-Kozlowska T. Ethanol affects acylated and total ghrelin levels in peripheral blood of alcohol-dependent rats. Addiction Biology 2013, (6):689-701.
95. Nilsson N.E., Kotarsky K., Owman C., Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochemical and Biophysical Research Communications 2003, 303(4):1047-1052.
96. Theil P.K., Jorgensen H., Serena A., Hendrickson J., Bach Knudsen K.E. Products deriving from microbial fermentation are linked to insulinaemic response in pigs fed breads prepared from whole-wheat grain and wheat and rye ingredients. British Journal of Nutrition 2011, 105(3):373-383.
97. Bach Knudsen K.E., Jorgensen H., Canibe N. Quantification of the absorption of nutrients derived from carbohydrate assimilation: model experiment with catheterised pigs fed on wheat- or oat-based rolls. British Journal of Nutrition 2000, 84(4):449-458.
98. Windmueller H.G., Spaeth A.E. Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. Quantitative importance of glutamine, glutamate, and aspartate. Journal of Biological Chemistry 1980, 255(1):107-112.
99. Vaugelade P., Posho L., Darcy-Vrillon B., Bernard F., Morel M.T., Duee P.H. Intestinal oxygen uptake and glucose metabolism during nutrient absorption in the pig. Proceedings of the Society for Experimental Biology and Medicine 1994, 207(3):309-316.
100. Fleming S.E., Zambell K.L., Fitch M.D. Glucose and glutamine provide similar proportions of energy to mucosal cells of rat small intestine. American Journal of Physiology 1997, 273(4 Pt 1):G968-G978.
101. Ahmed K., Tunaru S., Tang C., Muller M., Gille A., Sassmann A., et al. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metabolism 2010, 11(4):311-319.
102. Broom D.R., Stensel D.J., Bishop N.C., Burns S.F., Miyashita M. Exercise-induced suppression of acylated ghrelin in humans. Journal of Applied Physiology 2007, 102(6):2165-2171.
103. Broom D.R., Batterham R.L., King J.A., Stensel D.J. Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2009, 296(1):R29-R35.
104. Shiiya T., Ueno H., Toshinai K., Kawagoe T., Naito S., Tobina T., et al. Significant lowering of plasma ghrelin but not des-acyl ghrelin in response to acute exercise in men. Endocrine Journal 2011, 58(5):335-342.
105. Balaguera-Cortes L., Wallman K.E., Fairchild T.J., Guelfi K.J. Energy intake and appetite-related hormones following acute aerobic and resistance exercise. Applied Physiology, Nutrition, and Metabolism 2011, 36(6):958-966.
106. Chaiban J.T., Bitar F.F., Azar S.T. Effect of chronic hypoxia on leptin, insulin, adiponectin, and ghrelin. Metabolism 2008, 57(8):1019-1022.
107. Wasse L.K., Sunderland C., King J.A., Batterham R.L., Stensel D.J. Influence of rest and exercise at a simulated altitude of 4,000m on appetite, energy intake, and plasma concentrations of acylated ghrelin and peptide YY. Journal of Applied Physiology 2012, 112(4):552-559.
108. Brown E.M., Pollak M., Hebert S.C. Sensing of extracellular Ca2+ by parathyroid and kidney cells: cloning and characterization of an extracellular Ca(2+)-sensing receptor. American Journal of Kidney Diseases 1995, 25(3):506-513.
109. Reimann F., Tolhurst G., Gribble F.M. G-protein-coupled receptors in intestinal chemosensation. Cell Metabolism 2012, 15(4):421-431.
110. Davey A.E., Leach K., Valant C., Conigrave A.D., Sexton P.M., Christopoulos A. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor. Endocrinology 2012, 153(3):1232-1241.
111. 2+-sensing receptor are mediated by a phospholipase C/inositol 1,4,5-trisphosphate-independent pathway that requires G12, Rho, filamin-A, and the actin cytoskeleton. Journal of Biological Chemistry 2005, 280(24):22875-22882.
112. Makita N., Sato J., Manaka K., Shoji Y., Oishi A., Hashimoto M., et al. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(13):5443-5448.
113. Saffouri B., Weir G., Bitar K., Makhlouf G. Stimulation of gastrin secretion from the perfused rat stomach by somatostatin antiserum. Life Science 1979, 25(20):1749-1753.
114. Bauer B., Wex T., Kuester D., Meyer T., Malfertheiner P. Differential expression of human beta defensin 2 and 3 in gastric mucosa of Helicobacter pylori-infected individuals. Helicobacter 2013, 18(1):6-12.
115. Takahashi H., Kurose Y., Suzuki Y., Kojima M., Yamaguchi T., Yoshida Y., et al. Changes in blood pancreatic polypeptide and ghrelin concentrations in response to feeding in sheep. Journal of Animal Science 2010, 88(6):2103-2107.
116. Gagnon J., Anini Y. Glucagon stimulates ghrelin secretion through the activation of MAPK and EPAC and potentiates the effect of norepinephrine. Endocrinology 2013, 154(2):666-674.
117. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 2005, 11(1):90-94.
118. Zigman J.M., Westermark G.T., LaMendola J., Steiner D.F. Expression of cone transducin, Gz alpha, and other G-protein alpha-subunit messenger ribonucleic acids in pancreatic islets. Endocrinology 1994, 135(1):31-37.
119. Wang Y., Park S., Bajpayee N.S., Nagaoka Y., Boulay G., Birnbaumer L., et al. Augmented glucose-induced insulin release in mice lacking G(o2), but not G(o1) or G(i) proteins. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(4):1693-1698.
120. Kimple M.E., Joseph J.W., Bailey C.L., Fueger P.T., Hendry I.A., Newgard C.B., et al. Galphaz negatively regulates insulin secretion and glucose clearance. Journal of Biological Chemistry 2008, 283(8):4560-4567.
121. Lizarzaburu M., Turcotte S., Du X., Duquette J., Fu A., Houze J., et al. Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry Letters 2012, 22(18):5942-5947.
122. Ku G.M., Pappalardo Z., Luo C.C., German M.S., McManus M.T. An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production. PLoS Genetics 2012, 8(1):e1002449.
123. Meyer R.C., Giddens M.M., Schaefer S.A., Hall R.A. GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(23):9529-9534.